Expert Interview
Perusing the Phase 3 topline results from study 501 evaluating Lumateperone in patients with major depressive disorder.
Ticker(s): ITCIInstitution: Empower Psych Centers LLC
- Board certified psychiatrist with Empower Psych Centers LLC
- Currently manages 150 patients with Major Depressive Disorder per month
- Familiar with lumateperone and the study 501 that has been conducted
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
